What is DiA Imaging Analysis?
DiA Imaging Analysis is at the forefront of revolutionizing medical diagnostics by enhancing the use and analysis of ultrasound images. Founded in 2009 and based in Southern District, Israel, the company leverages AI-based technology to make sophisticated image analysis accessible to all clinicians. Their platform transforms how healthcare professionals capture and interpret ultrasound data, aiming to improve diagnostic accuracy and efficiency. The company's focus on AI in medical imaging positions it as a key player in the rapidly evolving health tech landscape, addressing critical needs in clinical decision-making.
How much funding has DiA Imaging Analysis raised?
DiA Imaging Analysis has raised a total of $19M across 2 funding rounds:
Unspecified
$5M
Series B
$14M
Unspecified (2018): $5M with participation from Israel Innovation Authority, DEFTA Partners, and Connecticut Innovations
Series B (2021): $14M led by Icon Advisers, Philips, Downing Ventures, DEFTA Partners, Alchimia Ventures, Connecticut Innovations, Mindset Ventures, CE Ventures, Dr Shmuel Cabilly, and XTX Ventures
Key Investors in DiA Imaging Analysis
Israel Innovation Authority
The Israel Innovation Authority is a government entity dedicated to fostering technological innovation within Israel, supporting startups and established companies through various funding programs and strategic initiatives.
DEFTA Partners
DEFTA Partners is a global venture investment firm specializing in innovative technologies within healthcare and ICT, with a track record of funding over 100 companies worldwide.
Connecticut Innovations
Connecticut Innovations is the state's strategic venture capital arm, providing financing and guidance to growing companies, with dedicated funds for sectors including AI and biosciences.
What's next for DiA Imaging Analysis?
With a recent major strategic investment, DiA Imaging Analysis is poised for accelerated growth and market expansion. The substantial capital infusion is expected to fuel further research and development, enhance product offerings, and broaden the company's global reach. This strategic backing will likely enable DiA Imaging Analysis to solidify its position as a leader in AI-driven ultrasound analysis, potentially leading to new partnerships and wider adoption of its technology in clinical settings worldwide. The company's focus on innovation and accessibility in medical imaging suggests a future centered on improving patient care through advanced technology.
See full DiA Imaging Analysis company page
